1 |
Graphene oxide–polyethylene glycol–chlorin e6 |
0.00138–0.011 mg/mL |
0.1 W/cm2 (10 min) |
24 h |
Human nasopharyngeal epidermal carcinoma KB cell line |
~10% cell viability |
[93] |
2 |
Folic-acid-conjugated graphene oxide–chlorin e6 |
0–100 μM |
~30 mW/cm2 (10 min) |
48 h |
MGC803 cells |
~10% cell viability |
[112] |
3 |
Graphene oxide– polyvinylpyrrolidone–chlorin e6 |
0–50 µM |
30 mW/cm2 (3 min) |
24 h |
MGC803 cells |
complete cell killing |
[113] |
4 |
Graphene–chlorin e6 |
0–0.20 µg/mL |
0.14 W/cm2 (2 min) |
24 h |
HeLa cells |
Up to 100% cell killing |
[114] |
5 |
Graphene oxide– polyethylene glycol–chlorin e6 |
0.25–2 µM |
0.2 W/cm2 (5 min) |
24 h |
HeLa cells |
10% cell viability |
[115] |
6 |
Folic-acid-conjugated polyethylenimine–PEGylated graphene–chlorin e6 |
0.5–10 µg/mL |
200 W/cm2 (5 min) |
24 h |
HeLa cells |
~15% cell viability |
[116] |
7 |
PEGylated nanographene–chlorin e6 |
0–2.0 µM |
0.1 W/cm2 (10 min) |
24 h |
4T1 cells |
Complete cell killing |
[117] |
8 |
Graphene oxide– polyethylene glycol–chlorin e6 |
50 µmol/L |
1.5 W at 808 nm |
1 h |
U87 cells |
10% cell viability |
[118] |
9 |
Chlorin e6–PEG-conjugated graphene oxide |
0–2.5 µg/mL |
2.0 J/cm2
|
24 h |
CCA cells |
10% cell viability |
[119] |
10 |
Up-conversion nanoparticles–graphene oxide–chlorin e6 |
25–800 µg/mL |
0.72 W/cm2 (10 min) |
24 h |
HeLa cells |
15% cell viability |
[86] |
11 |
Graphene oxide–chlorin e6 |
1.0 µM |
2 W/cm2 (15 min) |
3–24 h |
A549 cells |
IC50 = 0.69 at 3 h |
[120] |